BRIEF-Atea Pharmaceuticals Q4 Basic EPS USD -0.4

Reuters
07 Mar
BRIEF-Atea Pharmaceuticals Q4 Basic EPS USD -0.4

Mar 06 (Reuters) - Atea Pharmaceuticals Q4 operating income USD -39.026 million.

  • Q4 pretax profit USD -33.318 million
  • Q4 net income USD -33.543 million
  • Q4 operating expenses USD 39.026 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10